MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

5.01 0.2

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.01

Максимум

5.01

Ключови измерители
By Trading Economics
Приходи	1.3M -3M
Продажби	100K 100K
Марж на печалбата	-2,954
Служители	21

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	531K 40M
Предишно отваряне	4.81
Предишно затваряне	5.01

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.04.2026 г., 04:27 ч. UTC

Значими събития в новините

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

3.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

3.04.2026 г., 18:30 ч. UTC

Значими събития в новините

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3.04.2026 г., 18:14 ч. UTC

Пазарно говорене

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3.04.2026 г., 17:50 ч. UTC

Пазарно говорене

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3.04.2026 г., 17:44 ч. UTC

Придобивния, сливания и поглъщания

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3.04.2026 г., 16:50 ч. UTC

Значими събития в новините

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3.04.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

3.04.2026 г., 16:12 ч. UTC

Печалби

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3.04.2026 г., 15:56 ч. UTC

Пазарно говорене

Значими събития в новините

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3.04.2026 г., 15:56 ч. UTC

Пазарно говорене

Значими събития в новините

Global Equities Roundup: Market Talk

3.04.2026 г., 15:56 ч. UTC

Пазарно говорене

Значими събития в новините

Global Forex and Fixed Income Roundup: Market Talk

3.04.2026 г., 15:20 ч. UTC

Значими събития в новините

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3.04.2026 г., 15:08 ч. UTC

Придобивния, сливания и поглъщания

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3.04.2026 г., 14:11 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3.04.2026 г., 12:56 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3.04.2026 г., 08:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

3.04.2026 г., 08:01 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

3.04.2026 г., 08:01 ч. UTC

Пазарно говорене

Meituan's Profitability Likely to Improve This Year -- Market Talk

3.04.2026 г., 07:45 ч. UTC

Пазарно говорене

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3.04.2026 г., 06:17 ч. UTC

Пазарно говорене

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3.04.2026 г., 06:17 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

3.04.2026 г., 04:33 ч. UTC

Пазарно говорене

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3.04.2026 г., 04:33 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

3.04.2026 г., 04:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

3.04.2026 г., 04:01 ч. UTC

Пазарно говорене

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

3.04.2026 г., 02:01 ч. UTC

Пазарно говорене

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

3.04.2026 г., 01:59 ч. UTC

Пазарно говорене

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

3.04.2026 г., 01:44 ч. UTC

Пазарно говорене

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

3.04.2026 г., 01:22 ч. UTC

Пазарно говорене

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Печалба преди облагане с данъци

Продажби

Оперативна печалба

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.